Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Baloxavir Versus Oseltamivir for Influenza Outbreak Management in U.S. Nursing Homes

NCT05012189 is registered in ClinicalTrials.gov with Insight Therapeutics, LLC as lead sponsor.

NCT NCT05012189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Baloxavir Versus Oseltamivir for Influenza Outbreak Management in U.S. Nursing Homes
Lead sponsor
Insight Therapeutics, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
August 6, 2021
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza -like illness, influenza, human